Wednesday, 23 April 2025
Trending
Business

Abbott Fined $500 Million in NEC Case Involving Premature Infant Formula

  • Abbott Laboratories was fined $500 million by a jury over claims that its Similac Special Care 24 formula caused necrotizing enterocolitis (NEC) in a premature infant.
  • The jury awarded $95 million in compensatory damages and $400 million in punitive damages.
  • Abbott disputes the verdict, claiming there is no evidence linking its formula to NEC and plans to appeal.

Abbott Laboratories faces a substantial $500 million fine following a jury’s decision in St. Louis, where the company was held responsible for causing severe brain damage in a premature baby allegedly due to its Similac Special Care 24 formula.

The jury awarded nearly $500 million to the plaintiff, including both compensatory and punitive damages, highlighting concerns over the safety of the formula for premature infants.

Abbott Ordered to Pay $500 Million Over Alleged Risks of Infant Formula

Abbott Laboratories has firmly disputed the claims, arguing that there is no scientific evidence linking their formula to NEC. The company contends that the verdict is based on erroneous conclusions and plans to pursue an appeal to overturn the decision. Abbott’s defense highlighted that its products are considered standard care for premature infants, alongside mother’s milk and donor human milk.

The case is part of a broader wave of lawsuits against formula manufacturers, with similar claims targeting other companies like Reckitt Benckiser Group Plc. In a related case earlier this year, Reckitt was ordered to pay $60 million after a jury found its formula contributed to a premature baby’s death, leading to a significant drop in its shares.

The Abbott case underscores ongoing concerns about the safety of cow’s milk-based formulas for premature infants and could have widespread implications for the industry. As the legal battles continue, the outcome of Abbott’s appeal will be closely watched.

The $500 million verdict against Abbott highlights serious concerns about the safety of infant formulas for premature babies. With Abbott planning to appeal, this case could influence future regulations and litigation in the formula industry.

“Justice was served for Margo Gill and her daughter Robynn, who suffered severe, irreversible brain damage due to Abbott’s misconduct.”

Related posts
BusinessWorld

India Under US Pressure to Expand E-Commerce for Giants

Trump administration seeks full access for Amazon and Walmart in India. Current Indian rules…
Read more
Business

Steel Industry Growth: India’s 300 MT Goal by 2030

India targets 300 MT steel capacity and 160 kg per capita consumption by 2030 ₹17,000 crore…
Read more
Business

Elon Musk's 2025 Agenda: India on the Horizon

Musk to visit India later this year after speaking with PM Modi about tech and…
Read more
Newsletter
Become a Trendsetter

To get your breaking, trending, latest news immediately without diluting its truthfulness join with worldmagzine immediately.

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock Market

Asian Shares Plummet Amid Wall Street Tech Slump

Worth reading...